Edward V. Loftus
Impact in
- Genetics top 0.01%
- Inflammatory Bowel Disease
- Gastroenterology top 0.05%
Papers in
- Genetics 487
- Inflammatory Bowel Disease 486
- Epidemiology 247
- Microscopic Colitis 210
- Autoimmune and Inflammatory Disorders 29
- Co-authors
- William J. Sandborn (209 shared papers)William J. Tremaine (122 shared papers)William Scott Harmsen (84 shared papers)Alan R. Zinsmeister (67 shared papers)Jean Fred Colombel (48 shared papers)Darrell S. Pardi (81 shared papers)Laurent Peyrin‐Biroulet (30 shared papers)Remo Panaccione (57 shared papers)
- Journals
- Gastroenterology (126 papers)Inflammatory Bowel Diseases (124 papers)The American Journal of Gastroenterology (117 papers)Clinical Gastroenterology and Hepatology (48 papers)Journal of Crohn s and Colitis (43 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Edward V. Loftus
688 papers receiving 52.0k citations
Edward V. Loftus's Hit Papers
Peers
Comparison fields: 5 of 170
- Genetics 34.9k
- Gastroenterology 3.2k
- Epidemiology 16.6k
- Hepatology 2.4k
- Surgery 10.9k
Countries citing papers authored by Edward V. Loftus
This map shows the geographic impact of Edward V. Loftus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward V. Loftus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward V. Loftus more than expected).
Fields of papers citing papers by Edward V. Loftus
This network shows the impact of papers produced by Edward V. Loftus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward V. Loftus. The network helps show where Edward V. Loftus may publish in the future.
Co-authors
The 25 scholars most cited alongside Edward V. Loftus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 714 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology Hit paper breakdown → | 2005 | 2844 |
| 2 | Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences Hit paper breakdown → | 2004 | 2525 |
| 3 | Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target Hit paper breakdown → | 2015 | 1517 |
| 4 | Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease Hit paper breakdown → | 2016 | 1476 |
| 5 | ACG Clinical Guideline: Management of Crohn's Disease in Adults Hit paper breakdown → | 2018 | 1062 |
| 6 | The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study Hit paper breakdown → | 2001 | 935 |
| 7 | The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota Hit paper breakdown → | 2002 | 860 |
| 8 | Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease Hit paper breakdown → | 2008 | 860 |
| 9 | The Natural History of Adult Crohn's Disease in Population-Based Cohorts Hit paper breakdown → | 2009 | 830 |
| 10 | The safety profile of infliximab in patients with Crohn’s disease: The Mayo Clinic experience in 500 patients Hit paper breakdown → | 2003 | 761 |
| 11 | The safety of vedolizumab for ulcerative colitis and Crohn's disease Hit paper breakdown → | 2016 | 664 |
| 12 | Risk Factors Associated With Progression to Intestinal Complications of Crohn's Disease in a Population-Based Cohort Hit paper breakdown → | 2010 | 645 |
| 13 | 2004 | 604 | |
| 14 | Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis Hit paper breakdown → | 2019 | 562 |
| 15 | 1998 | 553 | |
| 16 | 2006 | 549 | |
| 17 | Geographical variability and environmental risk factors in inflammatory bowel disease Hit paper breakdown → | 2013 | 506 |
| 18 | Development of the Crohnʼs disease digestive damage score, the Lémann score Hit paper breakdown → | 2010 | 487 |
| 19 | 2005 | 483 | |
| 20 | 2008 | 461 |
About Edward V. Loftus
Edward V. Loftus is a scholar working on Genetics, Epidemiology, Gastroenterology, Surgery and Hepatology, having authored 714 papers that have together received 53.7k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (486 papers), Microscopic Colitis (210 papers), Eosinophilic Esophagitis (44 papers), Liver Diseases and Immunity (40 papers), Autoimmune and Inflammatory Disorders (29 papers), Diverticular Disease and Complications (28 papers), Helicobacter pylori-related gastroenterology studies (22 papers) and Celiac Disease Research and Management (22 papers). The work is most often cited by research in Genetics (34.9k citations), Gastroenterology (3.2k citations), Epidemiology (16.6k citations), Hepatology (2.4k citations) and Surgery (10.9k citations). Edward V. Loftus has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include William J. Sandborn, William J. Tremaine, William Scott Harmsen, Alan R. Zinsmeister, Jean Fred Colombel, Darrell S. Pardi, Laurent Peyrin‐Biroulet, Remo Panaccione, William A. Faubion and David H. Bruining. Their work appears in journals such as Gastroenterology, Inflammatory Bowel Diseases, The American Journal of Gastroenterology, Clinical Gastroenterology and Hepatology and Journal of Crohn s and Colitis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.